Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate ...

Photoimmunotherapy with the M@P nanoplatform offers a novel approach, triggering cancer cell death and boosting immune ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with ALK+ non-small cell lung cancer as seen in clinical practice.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Vaccines for cancer may have seem like a pipe dream a few years ago, but with the great work of scientists and researchers we have made great strides towards cancer treatments. This new vaccine may be ...

A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

In a paper published in National Science Review, an international team of scientists report a coordination nanomedicine ...